Used in the synthesis of pharmaceutical intermediates, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports selective binding to specific enzyme targets, enhancing drug potency and reducing off-target effects. Commonly employed in late-stage functionalization due to the silyl-protected alcohol group, allowing for further chemical modifications under mild conditions. Also utilized in research settings to explore new routes in asymmetric synthesis, taking advantage of its chiral centers for stereoselective transformations.